Novo’s Wegovy Approved After Superior Weight-Loss Impact Shown

Novo Nordisk A/S gained U.S. approval for its therapy that helped patients lose about 15% of their body weight on average in trials, an alternative to an existing treatment from the Danish drugmaker as well as invasive, costly obesity surgery.

Read more

Related News